title: [Brachyterapy in localized prostate cancer].
abstract: OBJECTIVE
  Considering the high frequency of localized prostate cancer in stages, at the moment there are minimally invasive techniques that compete with the classic surgery. One of them is the Low Dose Rate (LDR) Brachytherapy with permanent implants of 1125 seeds. The objective of the present study is to expose our experience from the year 1998, when we made the first treatment, until today. The results and the morbidity of the patients over a 7 and a half years period are analyzed.
  
  
  METHODS
  A total of 800 patients were treated with LDR brachytherapy, with average age of 68 years and range between 48 and 83 years. In all patients the 1125 seeds were used with Rapid-Strand and peripheral load by means of intraoperative planning.
  
  
  RESULTS
  The urinary rate of complications was of 3% of AUR, and 0.2% of urinary incontinence. The morbidity on the digestive apparatus was of a 12% intermittent bleeding, 2% of proctitis, and a 0.3% of rectal fistulas.
authors: Servicio Urología, Hospital Universitario Central de Asturias, Oviedo. josuvargas@hotmail.com
authors: J M
authors: JM
authors: Abascal Junquera
authors: M
authors: M
authors: Hevia Suarez
authors: J M
authors: JM
authors: Abascal García
authors: R
authors: R
authors: Abascal García
authors: H
authors: H
authors: Gonzalez Suárez
authors: A
authors: A
authors: Alonso
authors: G
authors: G
authors: Juan Rijo
authors: P J
authors: PJ
authors: Prada
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy*; D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D000075202:Contraindications; D007172:Erectile Dysfunction / Q000453:epidemiology / Q000209:etiology; D006471:Gastrointestinal Hemorrhage / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D007267:Injections; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011349:Proctitis / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D012003:Rectal Fistula / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D015996:Survival Rate; D014549:Urinary Incontinence / Q000453:epidemiology / Q000209:etiology
chemical_list: D007457:Iodine Radioisotopes; D006820:Hyaluronic Acid